Stock Track | Teladoc Health Soars 5.20% on Offering Eli Lilly's Obesity Drug Zepbound with Pharmacy Partner

Stock Track03-06

Teladoc Health Inc. (TDOC) saw its stock soar 5.20% during intraday trading on Thursday, following the announcement of a pharmacy integration agreement with Eli Lilly's LillyDirect pharmacy partner, Gifthealth. This agreement will provide Teladoc Health members enrolled in its Comprehensive Weight Care Program with access to the FDA-approved obesity drug Zepbound® (tirzepatide) through a self-pay option.

The integration with Gifthealth allows eligible Teladoc Health members without insurance coverage for glucagon-like peptide-1 receptor agonists (GLP-1s) for obesity to have single-use Zepbound® vials delivered directly to their homes. This move aims to reduce barriers to high-quality care and help members afford transformative FDA-approved treatments while avoiding the potential risks of compounded medications.

In addition to clinically appropriate medication access, Teladoc Health's Comprehensive Weight Care Program offers a multi-disciplinary, evidence-based approach with support from licensed clinicians, registered dietitians, and expert health coaches. Members receive personalized lifestyle coaching, nutrition counseling, mental health support, and proven behavior change resources to help manage and maintain a healthy weight.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190189656?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2025-03-06 22:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190189656","market":"hk","top_or_hot":-1,"title":"Stock Track | Teladoc Health Soars 5.20% on Offering Eli Lilly's Obesity Drug Zepbound with Pharmacy Partner","media":"Stock Track","content":"<p>Teladoc Health Inc. (TDOC) saw its stock soar 5.20% during intraday trading on Thursday, following the announcement of a pharmacy integration agreement with Eli Lilly's LillyDirect pharmacy partner, Gifthealth. This agreement will provide Teladoc Health members enrolled in its Comprehensive Weight Care Program with access to the FDA-approved obesity drug Zepbound® (tirzepatide) through a self-pay option.</p>\n\n<p>The integration with Gifthealth allows eligible Teladoc Health members without insurance coverage for glucagon-like peptide-1 receptor agonists (GLP-1s) for obesity to have single-use Zepbound® vials delivered directly to their homes. This move aims to reduce barriers to high-quality care and help members afford transformative FDA-approved treatments while avoiding the potential risks of compounded medications.</p>\n\n<p>In addition to clinically appropriate medication access, Teladoc Health's Comprehensive Weight Care Program offers a multi-disciplinary, evidence-based approach with support from licensed clinicians, registered dietitians, and expert health coaches. Members receive personalized lifestyle coaching, nutrition counseling, mental health support, and proven behavior change resources to help manage and maintain a healthy weight.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Teladoc Health Soars 5.20% on Offering Eli Lilly's Obesity Drug Zepbound with Pharmacy Partner</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Teladoc Health Soars 5.20% on Offering Eli Lilly's Obesity Drug Zepbound with Pharmacy Partner\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-03-06 22:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Teladoc Health Inc. (TDOC) saw its stock soar 5.20% during intraday trading on Thursday, following the announcement of a pharmacy integration agreement with Eli Lilly's LillyDirect pharmacy partner, Gifthealth. This agreement will provide Teladoc Health members enrolled in its Comprehensive Weight Care Program with access to the FDA-approved obesity drug Zepbound® (tirzepatide) through a self-pay option.</p>\n\n<p>The integration with Gifthealth allows eligible Teladoc Health members without insurance coverage for glucagon-like peptide-1 receptor agonists (GLP-1s) for obesity to have single-use Zepbound® vials delivered directly to their homes. This move aims to reduce barriers to high-quality care and help members afford transformative FDA-approved treatments while avoiding the potential risks of compounded medications.</p>\n\n<p>In addition to clinically appropriate medication access, Teladoc Health's Comprehensive Weight Care Program offers a multi-disciplinary, evidence-based approach with support from licensed clinicians, registered dietitians, and expert health coaches. Members receive personalized lifestyle coaching, nutrition counseling, mental health support, and proven behavior change resources to help manage and maintain a healthy weight.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TDOC","symbol_name":"Teladoc Health Inc.","start_time":0,"source_url":"","article_id":"1190189656","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190189656","pubTimestamp":1741272744,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Teladoc Health Inc.  saw its stock soar 5.20% during intraday trading on Thursday, following the announcement of a pharmacy integration agreement with Eli Lilly's LillyDirect pharmacy partner, Gifthealth. This agreement will provide Teladoc Health members enrolled in its Comprehensive Weight Care Program with access to the FDA-approved obesity drug Zepbound  through a self-pay option.The integration with Gifthealth allows eligible Teladoc Health members without insurance coverage for glucagon-li","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TDOC":"Teladoc Health Inc."},"translate_title":"Teladoc Health与药房合作伙伴提供礼来公司(Eli Lilly)的肥胖药物Zepbound，股价飙升5.20%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TDOC":1},"content_text":"Teladoc Health Inc. (TDOC) saw its stock soar 5.20% during intraday trading on Thursday, following the announcement of a pharmacy integration agreement with Eli Lilly's LillyDirect pharmacy partner, Gifthealth. This agreement will provide Teladoc Health members enrolled in its Comprehensive Weight Care Program with access to the FDA-approved obesity drug Zepbound® (tirzepatide) through a self-pay option.\nThe integration with Gifthealth allows eligible Teladoc Health members without insurance coverage for glucagon-like peptide-1 receptor agonists (GLP-1s) for obesity to have single-use Zepbound® vials delivered directly to their homes. This move aims to reduce barriers to high-quality care and help members afford transformative FDA-approved treatments while avoiding the potential risks of compounded medications.\nIn addition to clinically appropriate medication access, Teladoc Health's Comprehensive Weight Care Program offers a multi-disciplinary, evidence-based approach with support from licensed clinicians, registered dietitians, and expert health coaches. Members receive personalized lifestyle coaching, nutrition counseling, mental health support, and proven behavior change resources to help manage and maintain a healthy weight.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190189656"}